Please read and agree to the terms and conditions of this site.
@xconomy.com 4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com 5 years ago
After Scoring New Capital, Fifth Eye Prepares to Seek FDA Approval
@xconomy.com 5 years ago
Strangeworks, TMCx, SeriesX, Unchained Capital, ALTR, & More TX Tech
@xconomy.com 5 years ago
No Vital Signs Apparent at Wireless Health Specialist Awarepoint
@xconomy.com 5 years ago
Pfizer, Merck Lead Strata Oncology’s $26M Series B Round
@xconomy.com 5 years ago
Fictiv Raises $15M To Connect Tech Innovators & Parts Manufacturers